NASDAQ: ARGX - argenx SE

Yield per half year: +8.87%
Dividend yield: 0.00%
Sector: Healthcare

Share chart argenx SE

Extended chart Simple chart
Financial Markets by TradingView

About argenx SE

argenx SE, биотехнологическая компания клинической стадии, занимается разработкой методов лечения аутоиммунных заболеваний, гематологии и рака на основе антител. Он разрабатывает эфгартигимод, ведущий кандидат, для лечения пациентов с миастенией; иммунная тромбоцитопения в фазе III; вульгарная пузырчатка в фазе III; хроническая воспалительная демиелинизирующая полинейропатия в фазе III; и ENHANZE SC на доклинических стадиях.

more details
Компания также разрабатывает кузатузумаб на клинической стадии фазы II при гематологических показаниях к раку; ARGX-117 в фазе I клинических испытаний с терапевтическим потенциалом как при орфанных, так и при обширных аутоиммунных воспалительных заболеваниях; и доклинические продукты, в том числе ARGX-118 для лечения воспаления дыхательных путей. Его партнерские продукты-кандидаты включают ARGX-112 для лечения воспаления кожи, ARGX-116 для лечения дислипидемии и ARGX-115 для иммунотерапии рака, которые находятся на клинических стадиях фазы I; и ARGX-114 для лечения фиброза и ARGX-119 для лечения нервно-мышечных заболеваний, находящихся на доклинической стадии. Компания имеет стратегическое партнерство с AbbVie S.À.R.L. и ЛЕО Фарма А/С; и соглашение о сотрудничестве с Cilag GmbH International, Staten Biotechnology B.V. и Shire International GmbH. argenx SE была зарегистрирована в 2008 году и базируется в Бреде, Нидерланды.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2017-05-18
ISIN US04016X1019
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.argenx.com
Цена ао 605.52
Change price per day: -3.61% (605.52)
Change price per week: -4.79% (613.04)
Change price per month: -6.61% (624.94)
Change price per 3 month: -7.65% (632.04)
Change price per half year: +8.87% (536.11)
Change price per year: +48.24% (393.72)
Change price per 3 year: +80.24% (323.82)
Change price per 5 year: +408.86% (114.7)
Change price per year to date: -5.86% (619.96)
All parameters

Underestimation

Title Value Grade
P/S 17.38 1
P/BV 5.2 3
P/E 0 0
EV/EBITDA -87.37 0
Total: 2

Efficiency

Title Value Grade
ROA, % -6.5 0
ROE, % -7.2 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0906 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 1630.77 10
Yield Ebitda, % 16.11 3
Yield EPS, % 20.68 4
Total: 5
More

Institutions Volume Share, %
Bellevue Group AG 811 1.36
Morgan Stanley 694 1.17
Price (T.Rowe) Associates Inc 6 9.26
FMR, LLC 3 5.5
Artisan Partners Limited Partnership 3 5.37
Janus Henderson Group PLC 2 3.73
T. Rowe Price Investment Management, Inc. 2 3.56
Capital World Investors 2 3.14
Avoro Capital Advisors LLC 1 2.08
Blackrock Inc. 1 1.76

ETFShare, %Profitability for 1 year, %Dividends, %
VanEck Biotech ETF 5.67522 -2.87 0.80975
Tema Neuroscience and Mental Health ETF 4.79415 0
Tema Oncology ETF 4.19048 30.23 0.55
First Trust NYSE Arca Biotechnology Index Fund 3.55397 16.92 0.26101
Future Health ETF 2.64108 20.76
iShares Biotechnology ETF 2.44642 1.11 0.64399
Innovator IBD 50 ETF 1.84437 31.06 0.08939
Goldman Sachs Future Health Care Equity ETF 1.74185 16.15 0.84646
Invesco Nasdaq Biotechnology ETF 1.66528 28.58 0.8565
Future Tech ETF 1.66184 426.34 0.8416
Principal Healthcare Innovators ETF 1.66184 618.5 0.8416
American Century Mid Cap Growth Impact 1.58324 35.07 0.5636
American Century Focused Dynamic Growth ETF 1.46237 51.92 0.16246
Invesco NASDAQ Next Gen 100 ETF 1.14017 26.94 0.79805
ProShares Ultra Nasdaq Biotechnology 1.12627 51.7 0.85651
Global X S&P Catholic Values Developed ex-U.S. ETF 0.99051 12.36 3.19752
Invesco ESG NASDAQ Next Gen 100 ETF 0.85908 28.11 0.73691
JPMorgan International Growth ETF 0.69033 16.39 1.87508
Putnam Sustainable Future ETF 0.57957 32.87 0.70689
Pacer Trendpilot European Index ETF 0.54378 4.01 3.84163
Simplify Health Care ETF 0.5179 27.81 1.00373
Xtrackers MSCI Eurozone Hedged Equity ETF 0.50432 13.14 3.86046
T. Rowe Price Growth Stock ETF 0.46929 36.14 0.39083
ProShares UltraShort Nasdaq Biotechnology 0.4 -40.36 1.76
Wahed Dow Jones Islamic World ETF 0.39436 14.84 1.83837
Capital Group Global Growth Equity ETF 0.29822 23.31 1.87317
Matthews Asia Innovators Active ETF 0.29396 -99.36 2.43546
JPMorgan BetaBuilders Europe ETF 0.2793 5.19 3.612
Franklin FTSE Europe ETF 0.27454 8.4 3.62341
IQ Candriam International Equity ETF 0.26638 10.11 3.0914
FinEx Ex-USA ETF USD 0.26 45.15
SPDR Portfolio Europe ETF 0.24458 8.94 3.66537
Fidelity Growth Opportunities ETF 0.24093 32.75 0.48881
SPDR MSCI EAFE Fossil Fuel Free ETF 0.19738 11.72 3.25496
SPDR MSCI EAFE StrategicFactors ETF 0.19516 3.26 3.56855
JPMorgan BetaBuilders International Equity ETF 0.18083 4.72 3.37709
Goldman Sachs MarketBeta International Equity ETF 0.17922 5.33 3.36845
Xtrackers MSCI EAFE Hedged Equity ETF 0.17916 14.64 3.38114
Pacer Trendpilot International ETF 0.17864 12.96 3.28456
IQ FTSE International Equity Currency Neutral ETF 0.16754 11.13 3.27351
First Trust Nasdaq BuyWrite Income ETF 0.15257 7.27 0.92977
BNY Mellon International Equity ETF 0.15253 11.1 3.33394
Schwab International Equity ETF 0.15116 5.11 3.33884
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.12516 2.77 3.5165
SPDR Portfolio Developed World ex-US ETF 0.12413 5.29 3.28401
Xtrackers MSCI All World ex US Hedged Equity ETF 0.11462 18.18 3.26685
Vanguard ESG International Stock ETF 0.11 6.39 3.07501
SPDR MSCI ACWI ex-US ETF 0.10919 7.85 3.3217
SPDR MSCI World StrategicFactors ETF 0.10471 21.44 2.3827
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.08334 5.17 3.85434
Avantis Responsible International Equity ETF 0.05792 17.44 3.61591
Xtrackers MSCI Kokusai Equity ETF 0.04816 20.65 1.971
John Hancock Multifactor Developed International ETF 0.04563 3.14 3.77711
Avantis International Equity ETF 0.045 6.46 3.80856
Dimensional International Core Equity Market ETF 0.03884 13.09 3.48343
iShares MSCI ACWI ETF 0.03616 -19.68 2.10908
Adasina Social Justice All Cap Global ETF 0.03496 16.32 2.09739
SPDR Portfolio MSCI Global Stock Market ETF 0.03404 17.99 2.19607
Goldman Sachs ActiveBeta Europe Equity ETF 0.02131 7.9 3.59441
Dimensional International Core Equity 2 ETF 0.01843 6.52 3.69996
Dimensional World ex U.S. Core Equity 2 ETF 0.00256 13.06 3.62488
First Trust Long/Short Equity ETF -0.1165 17.29 1.96644
0.7729.142.19



Head Job title Payment Year of birth
Mr. Arjen Lemmen M.Sc. Vice President of Corporate Development & Strategy N/A 1985 (40 years)
Ms. Andria Wilk Global Head of Quality N/A 1974 (51 year)
Mr. Karl Gubitz Chief Financial Officer 843.26k 1970 (55 years)
Mr. Filip Borgions VP & Global Head of Technical Operations N/A
Ms. Beth DelGiacco VP and Global Head of Corporate Communications & Investor Relations N/A
Ms. Malini Moorthy General Counsel N/A 1970 (55 years)
Ms. Karen Massey Chief Operating Officer 1.42M 1979 (46 years)
Mr. Peter Ulrichts Chief Scientific Officer N/A 1980 (45 years)
Mr. Marc Schorpion Global Head of Human Resources N/A 1959 (66 years)
Mr. Timothy Van Hauwermeiren EMBA, M.Sc. CEO & Executive Director 1972 (53 years)

Address: Netherlands, Breda AH, Willemstraat 5 - open in Google maps, open in Yandex maps
Website: https://www.argenx.com